Today: 7 February 2026
Subscribe

Altria (MO) Stock This Week: CEO Succession, Dividend Update, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Altria (MO) Stock This Week: CEO Succession, Dividend Update, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Updated: December 12, 2025 (after market close) Altria Group, Inc. (NYSE: MO) ended the week on a quiet but steady note—closing at $58.75 on Friday, Dec. 12, extending a five-session grind higher from $58.11 on Dec. 8 (about +1.1% for the week). Investing.comWhile the broader market sold off on Friday, Altria’s shares were essentially unchanged on the day—an example of why income-focused investors often treat the tobacco giant as a defensive holding. MarketWatch+1 But “quiet price action” doesn’t mean “no catalysts.” Two company headlines landed back-to-back in the last few days—a leadership succession plan and a fresh dividend declaration—and they
14 December 2025
····
Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Milestone Pharmaceuticals (MIST) Stock Update: FDA Approves CARDAMYST (Etripamil) — This Week’s Volatility, Analyst Forecasts, and What to Watch Next (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) Milestone Pharmaceuticals Inc. (NASDAQ: MIST) closed out the week in the spotlight after the company announced U.S. FDA approval of CARDAMYST™ (etripamil)—positioning Milestone to transition from a development-stage biotech to a commercial-stage cardiovascular company. GlobeNewswire+1 The stock action was anything but calm. MIST closed at $2.41 on Dec. 12, down 18.31%, after swinging through a wide intraday range and printing exceptionally heavy volume. After-hours trading showed a modest rebound. StockAnalysis Below is a detailed breakdown of the latest Milestone Pharmaceuticals news, this week’s trading story, forecasts and analyst targets, and the week-ahead
14 December 2025
·····
MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

MercadoLibre Stock (NASDAQ: MELI) Weekly Update and Week-Ahead Outlook: Humanoid Robots Deal, $750M Notes, and Key Levels to Watch (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close)Meta description: MercadoLibre (MELI) ended the week near $2,016 after a volatile stretch that included a 5% midweek drop, a new humanoid-robot warehouse pilot, and a $750 million bond deal. Here’s what moved the stock this week and what investors are watching next week. MercadoLibre, Inc. (NASDAQ: MELI) closed Friday, Dec. 12, 2025 at $2,015.89, finishing a choppy week that featured a sharp selloff on Wednesday and a rebound attempt into the close. StockAnalysis The headline catalyst in the final days of the week wasn’t earnings—it was automation and capital markets. MercadoLibre announced a
14 December 2025
···
AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025)

AbbVie Stock Outlook (ABBV): Weekly Recap, Fresh Analyst Upgrades, and the Week-Ahead Setup (Updated Dec. 12, 2025)

AbbVie Inc. (NYSE: ABBV) ended the week of Dec. 8–12, 2025 near $223, after a choppy stretch that featured two notable Wall Street moves—an HSBC upgrade and a Morgan Stanley price-target hike—alongside ongoing headlines tied to AbbVie’s oncology and neuroscience pipeline. Yahoo Finance+2MarketBeat+2 For investors, the near-term story remains a familiar one: ABBV’s share price is being pulled between defensive-dividend appeal (especially in an uncertain macro backdrop) and the market’s ongoing debate over how durable AbbVie’s post-Humira growth engine will be—driven mainly by Skyrizi and Rinvoq, plus a deepening pipeline. AbbVie News Center+1 ABBV stock this week: Where AbbVie shares
14 December 2025
····
Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (MPW) Stock: This Week’s Slide, Tenant Headlines, Dividend Update, and What to Watch Next Week (Updated Dec. 12, 2025)

Medical Properties Trust (NYSE: MPW) ended the week near $5.10 after a sharp Thursday drop. Here’s what moved MPW stock this week, the latest tenant and legal headlines, analyst forecasts, and the key catalysts to watch in the week ahead. Medical Properties Trust, Inc. (NYSE: MPW) finished the Dec. 8–12 trading week under renewed pressure, closing Friday around $5.10 after a volatile stretch that included a sharp selloff on Thursday. Finviz For investors, MPW remains a story of two forces pulling in opposite directions: Below is a full “this week / week ahead” briefing—written for readers tracking MPW stock day
14 December 2025
····
NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) Stock Update: AI Data Center Deals, Higher 2026 EPS Outlook, and What to Watch Next Week (Updated Dec. 12, 2025)

NextEra Energy (NEE) closed at $81.65 on Dec. 12 after a headline-heavy week featuring new Google Cloud and Meta agreements, raised 2025–2026 EPS guidance, and fresh analyst price targets. NextEra Energy, Inc. (NYSE: NEE) ended Friday, Dec. 12, 2025, at $81.65. Yahoo Finance That close caps a volatile, news-packed week in which the company leaned hard into a single message for investors: power demand is accelerating, and the fastest-growing customers are increasingly AI and data-center developers—a trend NextEra believes can translate into multi-year earnings and dividend growth. NextEra Energy Investor Relations+1 Below is a complete, publication-ready breakdown of what moved
14 December 2025
·····
Coca-Cola Stock (KO) Outlook: CEO Transition, Dividend Week, Analyst Targets — Updated Dec. 12, 2025

Coca-Cola Stock (KO) Outlook: CEO Transition, Dividend Week, Analyst Targets — Updated Dec. 12, 2025

Updated: Friday, December 12, 2025 (U.S. market close)Company: The Coca-Cola Company (NYSE: KO) Coca-Cola stock ended the week near the $70 level after a choppy stretch of trading that included a sharp one-day dip and a strong Friday rebound. Investors are weighing a leadership transition set for 2026, the company’s steady “defensive” profile, and the next set of catalysts: a dividend payment on Monday (Dec. 15) and a data-heavy U.S. economic calendar that could influence interest rates—and by extension the appeal of dividend-focused stocks like KO. StockAnalysis+2StockAnalysis+2 KO stock recap: what happened this week (Dec. 8–Dec. 12) Coca-Cola shares closed
14 December 2025
·····
Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income (NYSE: O) Stock This Week: Dividend Hike, $800M Las Vegas Deal, and the Week-Ahead Setup (Updated Dec. 12, 2025)

Realty Income Corporation (NYSE: O) closed this week with investors balancing two fresh, shareholder-friendly headlines—a new dividend increase and a headline-grabbing $800 million preferred equity investment in CityCenter Las Vegas—against the bigger force that still tends to steer net-lease REITs: interest rates and bond yields. StockAnalysis Below is what moved Realty Income stock this week, what the latest announcements mean for income-focused investors, and what to watch in the week ahead as markets digest the Fed’s latest move and year-end positioning ramps up. Realty Income stock this week: a choppy slide despite positive company news Realty Income ended Friday, Dec.
14 December 2025
·····
DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

DoorDash Stock Forecast (DASH): News, Catalysts, and Week-Ahead Outlook After Friday’s $227.49 Close (Updated Dec. 12, 2025)

Updated: December 12, 2025 — DoorDash, Inc. (NASDAQ: DASH) ended Friday at $227.49, up 1.32% on the day, with a market value of roughly $99.6 billion. FinanceCharts+1 It was a volatile week for DoorDash stock: shares slid hard midweek as investors repriced the competitive outlook in online grocery and “instant” delivery, then stabilized as attention turned back to DoorDash’s scale, expansion strategy, and a fresh round of analyst updates. Investing.com+2Barron’s+2 Below is a comprehensive, publication-ready look at what moved DoorDash stock this week, the latest DoorDash news, and the key catalysts for the week ahead (Dec. 15–19). DoorDash stock price
13 December 2025
···
Altria (MO) Stock Update: New Dividend, CEO Succession, and What to Watch Next Week (Updated Dec. 12, 2025)

Altria (MO) Stock Update: New Dividend, CEO Succession, and What to Watch Next Week (Updated Dec. 12, 2025)

Updated: December 12, 2025 Altria Group, Inc. (NYSE: MO) ended Friday, Dec. 12, at $58.75, extending a string of modest daily gains and leaving the stock up roughly ~1%–1.3% over the last five sessions—a steady week for a high-yield, defensive name as investors digested two company-specific headlines: a CEO succession announcement and a fresh quarterly dividend declaration. StockAnalysis+2Reuters+2 With the market increasingly sensitive to interest rates and yield-based positioning, Altria’s “bond proxy” characteristics (plus its dividend that remains among the richer payouts in large-cap U.S. equities) keep MO on the watchlist for income-focused investors heading into the final full trading
13 December 2025
····
Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Nike Stock (NKE) This Week: Fed Rate Cut Fuels a Bounce as Earnings Loom — Latest News, Forecasts and Week-Ahead Setup (Updated Dec. 12, 2025)

Updated: December 12, 2025 (U.S. market close) Nike, Inc. (NYSE: NKE) heads into next week with its biggest near-term catalyst on the calendar: fiscal Q2 2026 earnings on Thursday, Dec. 18 (after the close). Nike Investor Relations After a volatile start to the week, Nike shares finished Friday at $67.47 (down 0.40% on the day) and ended the week up about 2.4% versus last Friday’s close. StockAnalysis The setup now is a familiar one for investors: a globally dominant brand in the middle of a turnaround (“Win Now”), facing tariff-driven cost pressure, digital and direct-to-consumer (DTC) traffic questions, and intensifying
13 December 2025
·····
McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

McKesson Stock Forecast: MCK Rebounds to $813.80 After Barclays’ Overweight Call — What to Watch Next Week (Updated Dec. 12, 2025)

Updated: Friday, December 12, 2025 (U.S. market close) McKesson Corporation (NYSE: MCK) ended the week on a steadier footing after an early-week dip, closing Friday at $813.80. The stock is still down roughly 9% from its late-November 52‑week high ($895.58 on Nov. 26), but it remains one of healthcare’s stronger large-cap performers in 2025 as investors continue to reward its specialty-drug and oncology momentum, capital returns, and portfolio reshaping narrative. MarketWatch+1 Below is a detailed recap of what moved McKesson stock this week, the latest company and analyst developments, and the key catalysts traders are watching in the week ahead.
13 December 2025
·····
1 … 1,572 1,573 1,574 1,575 1,576 … 2,713

Stock Market Today

Liberty Global stock price climbs as LBTYA pops and rare Class B spike rattles weekend watchlists

Liberty Global stock price climbs as LBTYA pops and rare Class B spike rattles weekend watchlists

7 February 2026
New York, Feb 7, 2026, 04:55 EST — Market closed Liberty Global’s Class A shares ended Friday at $11.75, up about 4.3%, after a sharp swing in the group’s less-traded Class B stock drew late-week attention on Nasdaq. Class C shares rose about 3.5%, while Class B jumped as much as 139% early in the session and touched a 52-week high of $29.01. (Seeking Alpha) The weekend setup matters because investors head into the new week looking for follow-through ahead of Liberty Global’s next results and after a new push into artificial intelligence tools. On Feb. 3, Liberty Global and
Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

Ashtead share price in focus as buyback rolls on and NYSE switch clocks closer

7 February 2026
Ashtead shares closed Friday at 4,936p, up 1.09%, after the company bought 88,872 shares under its repurchase program. The group is set to shift its primary listing to New York on March 2, pending court approval, and will be removed from the FTSE UK index the same day. Ashtead paid a half-year dividend of 37.5 U.S. cents per share on Friday.
Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

Beazley share price: big funds reshuffle stakes as Zurich bid deadline nears

7 February 2026
Beazley shares closed flat at 1,236 pence Friday as BlackRock disclosed a 6.55% stake and Vanguard reported 5.02%. Wellington Management cut its holding below 5%. The disclosures follow Zurich Insurance’s possible takeover offer of up to 1,335 pence per share, with a Feb. 16 deadline for a firm bid.
Go toTop